netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Ibrutinib found 6 matches
Open monograph to display formulary status BNF Category
  Ibrutinib  (Imbruvica®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (August 2017): Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia; risk of hepatitis B reactivation and of opportunistic infections (08.01.05)
link in drug section NICE TA429: Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation (08.01.05)
link in drug section NICE TA502: Ibrutinib for treating relapsed or refractory mantle cell lymphoma (08.01.05)
link in drug section NICE TA795: Ibrutinib for treating Waldenstrom’s macroglobulinaemia (08.01.05)
link in drug section NICE TA891: Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia (08.01.05)


 
netFormulary